Assuntos
Ácido Aminolevulínico/análogos & derivados , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/uso terapêutico , Sarcoma de Kaposi/tratamento farmacológico , Neoplasias Cutâneas/tratamento farmacológico , Adulto , Idoso de 80 Anos ou mais , Ácido Aminolevulínico/uso terapêutico , Humanos , MasculinoRESUMO
OBJECTIVE: To report a new case of prostatic carcinosarcoma, an uncommon and locally and distance aggressive tumor. METHOD: We analyzed one case diagnosed in our Center, from clinical and pathological diagnosis to death, describing the treatments received. RESULT: Patient presented a huge pelvic mass and a pulmonary metastasis that was treated with cystoprostatectomy and bilateral cutaneous ureterostomy with the diagnosis of carcinosarcoma of the prostate. He received 8 cycles of Docetaxel with bone progression and then 3 cycles of doxorubicin, suspending treatment due to progression. The survival was 18 months. CONCLUSIONS: Prostate carcinosarcoma is a very aggressive neoplasia that does not respond to the usual treatments of prostate cancer.
Assuntos
Carcinossarcoma , Neoplasias da Próstata , Idoso , Carcinossarcoma/diagnóstico , Carcinossarcoma/cirurgia , Humanos , Masculino , Neoplasias da Próstata/diagnóstico , Neoplasias da Próstata/cirurgiaAssuntos
Cateterismo Periférico/efeitos adversos , Hemorragia/etiologia , Artéria Radial , Dermatopatias Vesiculobolhosas/etiologia , Idoso , Biópsia , Diagnóstico Diferencial , Hemorragia/diagnóstico , Humanos , Masculino , Valor Preditivo dos Testes , Punções , Dermatopatias Vesiculobolhosas/diagnósticoRESUMO
OBJETIVO: Reportar un nuevo caso de carcinosarcoma prostático, un tumor infrecuente y agresivo localmente y a distancia. MÉTODO: Se ha analizado un único caso diagnosticado en nuestro Centro, desde el diagnóstico clínico y anatomopatológico hasta el éxitus, describiéndose los tratamientos recibidos por el mismo. RESULTADO: Paciente que presenta gran masa pélvica y una metástasis pulmonar que es sometido a cistoprostatectomia y ureterostomía cutánea bilateral con el diagnóstico de carcinosarcoma de próstata. Recibió 8 ciclos de Docetaxel objetivándose progresión ósea y posteriormente 3 ciclos de Doxorrubicina suspendiéndose por progresión. La supervivencia fue de 18 meses. CONCLUSIONES: El carcinosarcoma prostático es una neoplasia muy agresiva que no responde a los tratamientos habituales del cáncer de próstata
OBJECTIVE: To report a new case of prostatic carcinosarcoma, an uncommon and locally and distance aggressive tumor. METHOD: We analyzed one case diagnosed in our Center, from clinical and pathological diagnosis to death, describing the treatments received. RESULT: Patient presented a huge pelvic mass and a pulmonary metastasis that was treated with cystoprostatectomy and bilateral cutaneous ureterostomy with the diagnosis of carcinosarcoma of the prostate. He received 8 cycles of Docetaxel with bone progression and then 3 cycles of doxorubicin, suspending treatment due to progression. The survival was 18 months. CONCLUSIONS: Prostate carcinosarcoma is a very aggressive neoplasia that does not respond to the usual treatments of prostate cancer